The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital SignsEFT-ANXIETYNCT07348068
The Effect of the Emotional Freedom Technique Applied to Postmenopausal Women Before Probe Curettage on Pain, Anxiety and Vital Signs.
A study testing emotional freedom technique in people with The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital Signs, run by Kahramanmaras Sutcu Imam University at 3 sites in Turkey (Türkiye).
Trial summary
The aim of the study is to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs. Read more about this study
- Who is it for?
- Ages 18 to 75 years, women only
- Conditions the study is for
- The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital Signs
- What is being tested?
- emotional freedom technique
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 132 participants
- Where
- 3 sitesTurkey (Türkiye)
- Study dates
- 1 Feb 2025to 1 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Those who are in menopause
- Do not have conditions such as infection, wound or scar in the tapping areas,
- Having no problem communicating in Turkish,
- Those who have not used any analgesic medication in the last 24 hours,
- Those who have not had probe curettage before,
- Volunteer to participate in the study,
Show all 9Show fewer
- Not using any medication that directly affects vital signs,
- Does not have a disease that would cause problems in feeling pain,
- Not using antidepressants, anxiolytics and sedative agents.
Who cannot join
- • Those who are not in menopause
- Women who have had probe curettage before
- Their general condition deteriorates during the procedure or a different intervention is made with anesthesia,
- Any complications developed during the procedure,
- Those who experienced syncope during the procedure and the procedure was continued with general/local anesthesia,
- Having a psychiatric problem,
- Analgesic medication used during the procedure,
- Having cognitive, affective, perceptual problems.
Trial locations and contacts
3 sites in 1 country.
Turkey (Türkiye)3 sites
kahramanmaraş NFK Obstetrics and Pediatrics Hospital Additional Service Building
Kahramanmaraş, Kahramanmaraş, 4600
Kahramanmaraş Sütçü Imam Üniversitesi
Kahramanmaraş, Kahramanmaraş, 4600
Kahramanmaraş Sütçü Imam Üniversitesi
Kahramanmaraş, 4600
About this study
The aim of the study is to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.
Read the detailed description
In this experimentally designed study, it was aimed to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.
- Being tested
- emotional freedom technique
- Keywords
- Anxiety, Pain, and Vital Signs
- Medical subject headings
- Pain, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
emotional freedom techniqueBehavioural
In this study, the effect of emotional freedom technique on pain, anxiety, and vital signs prior to the probe curettage procedure will be examined. The EFT session will be administered by an EFT specialist approximately 40 minutes prior to the probe curettage procedure by tapping on the tapping points.
| Study group | Role | What they receive |
|---|---|---|
| EFT İNVERTİON GROUP | Experimental | During the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. EFT, which lasts approximately 30-40 minutes, will be administered to women by the researcher. Second measurement: Immediately after EFT, the SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again. Following the second measurement, the probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen satur Receives: Behavioral: emotional freedom technique |
| control group | No intervention | During the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Second measurement: The SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again simultaneously with the EFT group. Following the second measurement, a probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analogue Scale (VAS)
Pain intensity will be assessed using the Visual Analogue Scale (VAS), a numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Measured: Baseline (pre-procedure) and during the probe curettage procedure.
Secondary outcomes (4)
State-Trait Anxiety Inventory - State Version (STAI-I)
Anxiety levels will be assessed using the State-Trait Anxiety Inventory - State Version (STAI-I), which measures situational anxiety at a specific point in time. The scale consists of 20 items, with total scores ranging from 20 to 80. Higher scores indicate greater levels of anxiety.
Measured: Baseline (pre-procedure) and immediately post-procedure.
Systolic and Diastolic Blood Pressure
Systolic and diastolic blood pressure will be measured to evaluate physiological responses associated with the probe curettage procedure and the effect of the Emotional Freedom Technique (EFT).
Measured: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Heart Rate
Heart rate will be measured to assess autonomic physiological responses related to anxiety, pain, and procedural stress during the probe curettage procedure.
Measured: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Peripheral Oxygen Saturation (SpO₂)
Peripheral oxygen saturation will be measured to monitor respiratory and physiological stability during and after the probe curettage procedure.
Measured: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jan 2026
- Study start1 Feb 2025
- Primary completion1 Dec 2025
- Study completion1 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital SignsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- "This study uses a behavioral intervention model in which Emotional Freedom Techniques (EFT) are applied to postmenopausal women prior to a probe curettage procedure to examine its effects on pain, anxiety, and quality of life. EFT is a technique that involves gently tapping on specific acupuncture points while focusing on emotional distress. The intervention aims to reduce anxiety related to pain and improve overall quality of life. The study will evaluate the effectiveness of EFT applied prior to the probe curettage procedure on pain, anxiety, and quality of life during the procedure in postmenopausal women."
- Masking
- None (open label)
- Enrolment
- 132 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elif Elmas, Kahramanmaras Sutcu Imam University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07348068
- Sponsor's protocol ID
- KSU-MED-TRIAL-01
- Other IDs
- 2024/109
- Acronym
- EFT-ANXIETY
- Status last verified
- Jan 2026
- First submitted
- 21 Jan 2025
- Last updated
- 16 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The individual participant data (IPD) will not be shared due to privacy concerns and to ensure confidentiality of personal information. Additionally, the data is collected for a specific study and will not be made available for secondary analyses.
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of the Emotional Freedom Technique Applied to Postmenopausal Women Before Probe Curettage on Pain, Anxiety and Vital Signs.
- ClinicalTrials.gov ID
- NCT07348068
- Acronym / sponsor ID
- EFT-ANXIETY / KSU-MED-TRIAL-01
- Keywords
- Anxiety, Pain, and Vital Signs
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 132 participants (actual)
- Lead sponsor
- Kahramanmaras Sutcu Imam UniversityUniversity, hospital or other
- Study start
- 1 Feb 2025 (actual)
- Primary completion
- 1 Dec 2025 (actual)
- Study completion
- 1 Jan 2026 (actual)
- First posted
- 16 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.
Detailed description
In this experimentally designed study, it was aimed to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- "This study uses a behavioral intervention model in which Emotional Freedom Techniques (EFT) are applied to postmenopausal women prior to a probe curettage procedure to examine its effects on pain, anxiety, and quality of life. EFT is a technique that involves gently tapping on specific acupuncture points while focusing on emotional distress. The intervention aims to reduce anxiety related to pain and improve overall quality of life. The study will evaluate the effectiveness of EFT applied prior to the probe curettage procedure on pain, anxiety, and quality of life during the procedure in postmenopausal women."
| Arm | Type | Receives |
|---|---|---|
| EFT İNVERTİON GROUP | Experimental | Behavioral: emotional freedom techniqueDuring the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. EFT, which lasts approximately 30-40 minutes, will be administered to women by the researcher. Second measurement: Immediately after EFT, the SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again. Following the second measurement, the probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen satur |
| control group | No intervention | –During the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Second measurement: The SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again simultaneously with the EFT group. Following the second measurement, a probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Those who are in menopause
- Do not have conditions such as infection, wound or scar in the tapping areas,
- Having no problem communicating in Turkish,
- Those who have not used any analgesic medication in the last 24 hours,
- Those who have not had probe curettage before,
Key exclusion criteria (8 listed)
- • Those who are not in menopause
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| emotional freedom techniqueIn this study, the effect of emotional freedom technique on pain, anxiety, and vital signs prior to the probe curettage procedure will be examined. The EFT session will be administered by an EFT specialist approximately 40 minutes prior to the probe curettage procedure by tapping on the tapping points. | Behavioural | EFT İNVERTİON GROUP |
Primary outcome
Visual Analogue Scale (VAS)
Time frame: Baseline (pre-procedure) and during the probe curettage procedure.
Pain intensity will be assessed using the Visual Analogue Scale (VAS), a numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
4 secondary outcomes
State-Trait Anxiety Inventory - State Version (STAI-I)
Time frame: Baseline (pre-procedure) and immediately post-procedure.
Systolic and Diastolic Blood Pressure
Time frame: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Heart Rate
Time frame: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Peripheral Oxygen Saturation (SpO₂)
Time frame: Baseline (pre-procedure), during the probe curettage procedure, and immediately post-procedure (within 2 minutes after completion).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2026.
- "This link redirects to the website of Sütçü İmam University."Link provided by the sponsor.
- Individual participant dataSharing planned: No. The individual participant data (IPD) will not be shared due to privacy concerns and to ensure confidentiality of personal information. Additionally, the data is collected for a specific study and will not be made available for secondary analyses.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing emotional freedom technique in people with The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital Signs, run by Kahramanmaras Sutcu Imam University at 3 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analogue Scale (VAS) (time frame: Baseline (pre-procedure) and during the probe curettage procedure.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.